Skip To Main Content
Barbara Sheehan Withers on Muck Rack

Barbara Sheehan Withers

As seen in: Nature, Wiley, Wiley Online Library, Memory Studies, Tallahassee Democrat, emerald insight
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara Sheehan

Contact Barbara Sheehan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases

|
By Sarah Childs, David Ma, Elizabeth Houghton, Rasha Cosman, Jennifer Massey, Venessa T. Chin, Amanda L. McLaughlin, Simon Goodwin, Barbara Sheehan Withers, Callie Noakes, Annabel Horne, Jessica Boyd, Dion Forstner, Anthony J Rodrigues, Geeta Sandhu, Karim Ibrahim, Chloe Martin, Benjamin Kwan, Hergen Buscher, Philip J. Cunningham, Anthony M. Joshua, Laila Girgis, Ben Tran, Jayesh Desai, Simon Harrison, John Moore, Jia Liu, Valerie Valencia, Aaron O’Grady, Simone Kay Jensen, Helen Tao, Paul Preisz, Nicolas De Luca
| Nature Verified
Abstract Adoptive cellular therapies have revolutionised treatment of haematological malignancies and demonstrate potential in solid tumours and autoimmune disease. Real-world implementation remains limited by biological, logistical, and manufacturing barriers, restricting global uptake despite a rapidly expanding clinical trial portfolio. Effective implementation requires national and institutional readiness, multidisciplinary collaboration, scalable manufacturing, and robust infrastructure.
Open in Who Shared Issue with article?

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis

|
By Xavier Brennan, Barbara Sheehan Withers, Andrew Jabbour, Sam Milliken
| Wiley Online Library Verified
Abstract Cardiac light chain (AL) amyloidosis is a condition with a very poor prognosis. We report a retrospective analysis comparing the traditional melphalan and dexamethasone protocol with cyclophosphamide, bortezomib and dexamethasone in late-stage cardiac AL amyloidosis. The primary end points were overall survival and haematological response. Both regimens provided meaningful responses in this difficult to treat patient group.
Open in Who Shared Issue with article?

Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis

|
By Sophie Chatterton, Barbara Sheehan Withers, Ian Sutton, Samuel T Milliken
| Memory Studies
Show all authors Sophie Chatterton Department of Neurology, St Vincent’s Hospital Sydney, Darlinghurst, NSW, Australia/St Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia View ORCID profile See all articles by this author , Barbara Withers St Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia/Department of Haematology and Bone Marrow Transplantation, St Vincent’s Health Network, Darlinghurst, NSW, Australia/Kinghorn...
Open in Who Shared Issue with article?
See all 5 licensed articles (6 Total)